Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations

This publication has 29 references indexed in Scilit:

• Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
  Circulation, 1995
• Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients
  The Lancet, 1994
• Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).
  Circulation, 1994
• Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)
  The American Journal of Cardiology, 1993
• Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
  Circulation, 1992
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.
  Circulation, 1990
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Retardation of angiographic progression of coronary artery disease by nifedipine
  The Lancet, 1990
• Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis
  New England Journal of Medicine, 1985